John Clark's Insider Trades & SAST Disclosures
John Clark's most recent trade in BRC Inc - Ordinary Shares - Class A was a trade of 536,620 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Clark.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 536,620 | 536,620 | - | - | Stock Option (right to buy) | |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 105,140 | 275,607 | - | 0 | Class A Common Stock | |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.57 per share. | 23 Feb 2025 | 5,687 | 170,467 | - | 2.6 | 14,616 | Class A Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 28.77 per share. | 01 Jan 2025 | 825 | 37,618 (0%) | 0% | 28.8 | 23,735 | Common Stock |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | 31 Dec 2024 | 3,131 | 176,154 | - | 4.4 | 13,682 | Class A Common Stock | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 29.49 per share. | 01 Oct 2024 | 805 | 36,793 (0%) | 0% | 29.5 | 23,739 | Common Stock |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.90 per share. | 15 Aug 2024 | 1,185 | 179,285 | - | 3.9 | 4,622 | Class A Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 29.74 per share. | 01 Jul 2024 | 798 | 35,988 (0%) | 0% | 29.7 | 23,733 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.82 per share. | 17 May 2024 | 7,411 | 180,470 | - | 5.8 | 43,132 | Class A Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 32.88 per share. | 01 Apr 2024 | 722 | 35,190 (0%) | 0% | 32.9 | 23,739 | Common Stock |
| BRC Inc - Ordinary Shares ... | John Christopher Clark | CTO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 309,839 | 309,839 | - | - | Stock Option (right to buy) | |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 57,545 | 187,881 | - | 0 | Class A Common Stock | |
| Thermon Group Holdings Inc | U. Clarke John | Director | Purchase of securities on an exchange or from another person at price $ 25.01 per share. | 05 Feb 2024 | 5,000 | 34,468 (0%) | 0% | 25.0 | 125,050 | Common Stock |
| Thermon Group Holdings Inc | John Clarke U. | Director | Grant, award, or other acquisition of securities at price $ 32.57 per share. | 01 Jan 2024 | 729 | 29,468 (0%) | 0% | 32.6 | 23,744 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 27.74 per share. | 01 Oct 2023 | 864 | 28,739 (0%) | 0% | 27.7 | 23,967 | Common Stock |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2023 | 78,442 | 78,442 | - | - | Stock Option (right to buy) | |
| BRC Inc - Ordinary Shares ... | Christopher John Clark | CTO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2023 | 14,607 | 130,336 | - | 0 | Class A Common Stock | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 26.60 per share. | 01 Jul 2023 | 892 | 27,875 (0%) | 0% | 26.6 | 23,727 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Atyr Pharma Inc | John K. Clarke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,000 | 0 | - | - | Restricted Stock Unit | |
| Atyr Pharma Inc | John K. Clarke | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,000 | 19,797 (0%) | 0% | - | Common Stock | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 24.92 per share. | 01 Apr 2023 | 953 | 26,983 (0%) | 0% | 24.9 | 23,749 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 20.08 per share. | 01 Jan 2023 | 1,182 | 26,030 (0%) | 0% | 20.1 | 23,735 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 15.41 per share. | 01 Oct 2022 | 1,541 | 24,848 (0%) | 0% | 15.4 | 23,747 | Common Stock |
| Ethan Allen Interiors, Inc. | John Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,995 | 3,995 | - | - | Stock Option (right to buy) | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 14.35 per share. | 01 Jul 2022 | 1,655 | 23,307 (0%) | 0% | 14.3 | 23,749 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 6,000 | 6,000 | - | - | Restricted Stock Units | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 16.25 per share. | 01 Apr 2022 | 1,461 | 21,652 (0%) | 0% | 16.2 | 23,741 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 16.93 per share. | 01 Jan 2022 | 1,402 | 20,191 (0%) | 0% | 16.9 | 23,736 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 17.80 per share. | 01 Oct 2021 | 1,334 | 18,789 (0%) | 0% | 17.8 | 23,745 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 17.06 per share. | 01 Jul 2021 | 1,392 | 17,455 (0%) | 0% | 17.1 | 23,748 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.34 per share. | 21 May 2021 | 2,500 | 108,083 (1%) | 0% | 4.3 | 10,850 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 1,428 | 1,428 | - | - | Stock Option (right to buy) | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 19.34 per share. | 01 Apr 2021 | 1,228 | 16,063 (0%) | 0% | 19.3 | 23,750 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 1,519 | 14,835 (0%) | 0% | 0 | Common Stock | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 2,079 | 13,316 (0%) | 0% | 0 | Common Stock | |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.01 per share. | 28 Aug 2020 | 7,260 | 110,583 (1%) | 0% | 4.0 | 29,113 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 28 Aug 2020 | 100 | 117,843 (1%) | 0% | 4 | 400 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.09 per share. | 26 Aug 2020 | 5,440 | 117,943 (1%) | 0% | 4.1 | 22,250 | Common Stock |
| Atyr Pharma Inc | John K. Clarke | Director | Sale of securities on an exchange or to another person at price $ 4.30 per share. | 26 Aug 2020 | 2,200 | 123,383 (1%) | 0% | 4.3 | 9,451 | Common Stock |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 1,674 | 11,237 (0%) | 0% | 0 | Common Stock | |
| Atyr Pharma Inc | John K. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 1,428 | 1,428 | - | - | Stock Option (right to buy) | |
| Thermon Group Holdings Inc | John U. Clarke | Director | Grant, award, or other acquisition of securities at price $ 14.05 per share. | 01 Apr 2020 | 1,690 | 9,563 (0%) | 0% | 14.1 | 23,745 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges